An analytical method using ultra performance liquid chromatography (UPLC) quadrupole time-offlight mass spectrometry (QTOF-MS) was developed and validated for the targeted toxicological screening and quantification of commonly used pharmaceuticals and drugs of abuse in postmortem blood using 100 µL sample. It screens for more than 185 drugs and metabolites and quantifies more than 90 drugs. The selected compounds include classes of pharmaceuticals and drugs of abuse such as: antidepressants, antipsychotics, analgesics (including narcotic analgesics), antiinflammatory drugs, benzodiazepines, beta-blockers, amphetamines, new psychoactive substances (NPS), cocaine and metabolites. Compounds were extracted into acetonitrile using a salting-out assisted liquid-liquid extraction (SALLE) procedure. The extracts were analyzed using a Waters ACQUITY UPLC coupled with a XEVO QTOF mass spectrometer. Separation of the analytes was achieved by gradient elution using Waters ACQUITY HSS C18 column (2.1 mm x 150 mm, 1.8 μm). The mass spectrometer was operated in both positive and negative electrospray ionization modes. The high-resolution mass spectrometry (HRMS) data was acquired using a patented Waters MS E acquisition mode which collected low and high energy spectra alternatively during the same acquisition. Positive identification of target analytes was based on accurate mass measurements of the molecular ion, product ion, peak area ratio and retention times. Calibration curves were linear over the concentration range 0.05-2 mg/L for basic and neutral analytes and 0.1-6 mg/L for acidic analytes with the correlation coefficients (r 2 ) > 0.96 for most analytes. The limits of detection (LOD) were between 0.001-0.05 mg/L for all analytes. Good recoveries were achieved ranging from 80% to 100% for most analytes using the SALLE method. The method was validated for sensitivity, selectivity, accuracy, precision, stability, carryover and matrix effects. The developed method was tested on a number of authentic forensic samples producing consistent results that correlated with results obtained from other validated methods.
Introduction
In recent years there has been an increased interest from clinical and forensic toxicologists in the use of high-resolution mass spectrometry (HRMS) coupled to ultra performance liquid chromatography (UPLC) instruments (1) (2) (3) (4) (5) (6) . It is a result of innovative developments in HRMS technologies, including time-of-flight (TOF) and Orbitrap Fourier-transform mass analysers. The introduction of sensitive hybrid instruments such as quadrupole time-of-flight (QTOF), with higher resolution and greater mass accuracy, has made it possible to collect accurate masses of both the precursor and its product ions after collision-induced dissociation (CID). This has resulted in improved confidence in the identification of analytes in systematic toxicological analyses (STA). QTOF detectors coupled with UPLC instruments can offer shorter run times, analysis of aqueous samples and polar analytes with large molecular masses. QTOF instruments are also gaining popularity over conventional tandem mass spectrometers such as triple quadrupole mass spectrometers (MS/MS) because they record all masses simultaneously. They also provide retrospective data interrogation which allows for the re-assessment of samples for new analytes of interest without having to acquire new data. With the reduction of size and cost of modern instruments, there has been an increase in publications regarding the implementation of HRMS technology for the screening and quantification of illicit and medicinal drugs (2, 3, 5) .
Most methods using LC-QTOF-MS for forensic and clinical toxicology are related to the development of screening methods for different biological matrices, such as blood and plasma (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) , urine (11, (21) (22) (23) (24) (25) (26) , hair (27) (28) (29) and meconium (30) . However, there is little published data on the performance of this technique for quantitative analysis (15-19, 27, 28) .
The Waters XEVO QTOF mass spectrometer offers MS E , a patented data acquisition mode that collects low and high energy spectra alternatively during the same acquisition. The first function acquires data in a low energy state providing the exact mass of precursor ions. The second function, acquired in an elevated energy state, provides the exact mass of product ions for additional confirmatory purposes (13, 19) . This article focuses on the development and validation of an analytical method which demonstrates the ability of UPLC-QTOF-MS to provide both qualitative and quantitative information for over 185 toxicologically relevant drugs and metabolites in postmortem and ante-mortem blood samples.
Preparation of stock solutions, working solutions and internal standard (IS) solutions
The basic analytes selected for quantification (n = 78) were divided into four groups -two groups containing 19 analytes and two groups containing 20 analytes. Individual analytes within a group, each 1 mg/mL, were combined in a 5-mL volumetric flask and diluted with methanol so that the final concentration for each analyte was 40 mg/L. A basic mixed working standard solution (B) was prepared by combining 1 mL from each group to produce a 4 mL solution with a final concentration of 10 mg/L for all analytes.
The acidic mixed working standard (A) (n = 17) was prepared by combining the 17 individual analytes, each 1 mg/mL, and diluting with methanol in a 5-mL volumetric flask to a final concentration of 50 mg/L for each analyte. All analytes selected for quantification are listed in Table I. A mixed working standard (C) containing analytes targeted for screening only (n = 93) was prepared by diluting 10 mg/L stock solutions to a concentration of 0.5 mg/L. The classes of analytes in this working standard were benzodiazepines (n = 18), narcotic analgesics (n = 23), amphetamines (n = 6), new psychoactive substances (NPS) (n = 40) and other related substances (n = 5). A detailed list of the analytes in mixed standard C is presented in Table II .
The standard solutions were vortexed thoroughly and stored in a refrigerator at 4 o C. The analytes in this mixed standard were used for screening only as quantification was achieved on methods by LC-MS/MS and GC-MS that were developed in-house.
Three internal standards were used in this study: methadone-d 3, prazepam and cyclobarbitone. Stock solutions of methadone-d 3, prazepam and cyclobarbitone were prepared by diluting the 1 mg/mL standards with a saturated sodium chloride (NaCl) solution to give working solution concentrations of 0.1, 0.6 and 3 mg/L respectively. The solutions were vortexed, ultrasonicated and then placed on a roller mixer for 30 min before being stored in the refrigerator (4 o C).
Calibrators and Quality Control (QC) samples
Calibrators were prepared by dispensing appropriate volumes of acidic and basic mixed working solutions into 7-mL polypropylene tubes to give concentrations of 0.05, 0.2, 0.5, 0.8, 1.1, 1.4, 1.7 and 2 mg/L for basic analytes and 0.1, 0.5, 1, 2, 3, 4, 5 and 6 mg/L for acidic analytes, and evaporated under nitrogen until just dry. The resulting residue was reconstituted with 4 mL of blank blood, vortexed and placed on a roller mixer for 1 h. Quality control (QC) samples were prepared at three different levels: low, medium and high. A representative sample of 18 analytes (14 basic and 4 acidic) was used to prepare the QC samples. Low and high QC concentrations for basic analytes were 0.3 mg/L and 1.8 mg/L respectively and for acidic analytes were 1 mg/L and 5 mg/L respectively. The medium QC standard was purchased from UTAK laboratories (Valencia, CA, USA) and prepared at 1 mg/L for basic analytes and 3 mg/L for acidic analytes. QC samples were prepared in blank blood as previously described for the calibrator samples. Aliquots (0.5 mL) of all calibrators and QCs were dispensed into sealable plastic vials which were stored in a freezer (−18 o C).
Specimens
Blank blood used for method validation was prepared from expired Red Cross red cells and serum/plasma mixed in a 1:1 ratio and was screened for the presence of any target analytes. For the selectivity, matrix effects (ME) and recovery studies, non-decomposed (n-dec), decomposed (dec) and highly decomposed (h-dec) postmortem blood were evaluated. The degree of decomposition was estimated by both visual observation of the sample and instrumental analyses such as gas chromatography -mass spectrometry (GC-MS) and high performance liquid chromatography -photodiode array (HPLC-PDA) detection. The presence of human tissue putrefactive products such as indole, tryptamine and 2-phenethylamine were monitored and used to determine the level of decomposition (31) . A single sample of each postmortem blood type (i.e., n-dec, dec and h-dec) was obtained from forensic toxicology cases which were negative for the panel of selected analytes. Blood specimens were stored in a refrigerator (4 o C) until required for analysis.
Extraction procedure
All samples were brought to room temperature prior to extraction by placing on a rotator mixer. To a 7-mL polypropylene round-bottom tube, 100 µL blood was added to 300 µL IS solution and vortexed for 20 s, followed by ultrasonication for 15 min. Acetonitrile (3 mL) was then added to each tube which was then immediately capped, vortexed for 1 min, sonicated for 15 min and then placed on an IntelliMixer (ELMI) for 20 min. Each tube was then centrifuged at 6,000 rpm for 10 min. The upper organic layer was recovered and transferred into a 5-mL polypropylene flat based tube and dried under a gentle stream of nitrogen at room temperature. The residue was reconstituted using 200 µL of methanol: mobile phase A1 (1:1) and then transferred to a plastic 300-µL TPX micro-vial. Vials were capped with lids with presplit septa.
Instrumental analysis
Analysis of the whole blood extracts was performed using a Waters ACQUITY UPLC system coupled to a XEVO QTOF-MS. Chromatographic separation was achieved by injecting 2 µL of the extract onto a Waters ACQUITY UPLC HSS C18 column (150 mm x 2.1 mm, 1.8 µm particle size, average lifetime = 5000 injections), isothermal at 50 o C and using gradient elution with a flow rate of 0.4 mL/min. Two different sets of mobile phases were used -one for acidic analytes and one for basic analytes. For basic analytes: mobile phase A1 consisted 5 mM ammonium formate (pH=3) and mobile phase B1 consisted of acetonitrile containing 0.1 % (v/v) formic acid. Initial mobile phase conditions were 87% A1 for 0.5 min then was decreased linearly to 50% A1 over 9.5 min, followed by 5% over 0.75 min, held for 1.5 min then returning to 87% A1 over 0.25 min and held for 2.5 min giving a run time of 15 min. For acidic analytes, mobile phase A2 and B2 consisted of 0.05% (v/v) acetic acid in Milli-Q water and acetonitrile respectively. The mobile phase gradient for acidic analytes was specifically developed to separate amylobarbitone and pentobarbitone. Initial mobile phase conditions were 87% A2 for 0.5 min then was decreased linearly to 70% A2 over 7.0 min, 5% over 3.25 min and then held for 1.5 min, returning to 87% A over 0.25 min and held for 3.5 min giving a run time of 16 min.
The QTOF detector was operated in full scan mode (i.e TOF mode) using positive (ESI+) and negative (ESI-) electrospray ionization modes in separate injections for basic and acidic drugs respectively. Capillary voltages for ESI+ and ESI− modes were 0.80 kV and 2.0 kV respectively and the sampling cone voltage was 20 V. The source temperature was 150 o C and the desolvation temperature was 450 o C with the desolvation gas flow rate of 800 L/h. Argon was used as the collision gas with the gas pressure set at 3.5 × 10 3 mbar. The high resolution mass data were recorded using Waters MS E acquisition mode with full exact masses collected simultaneously by rapidly alternating between two functions. Function 1 acquired data with a low collision energy of 6 eV, and function 2 acquired data using a collision energy ramp of 10-40 eV. Sodium formate was used for the calibration of 185 Simultaneous Screening and Quantification of Basic, Neutral and Acidic Drugs in Blood Using UPLC-QTOF-MS the MS in positive and negative electrospray modes over a mass range of m/z 50-1000 with a resolution of approximately 10 000 FWHM (full width at half maximum). A lock mass solution of leucine enkephalin (m/z 556.2771 and m/z 554.2615 for positive and negative electrospray modes respectively) was infused through a Lock Spray probe at a flow rate of 10 µL/min at 40 s intervals to correct any mass drift during analysis.
Method Validation
The reported method was validated for selectivity, calibration/ linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), matrix effects, recovery, carryover, dilution integrity and stability according to internationally recognized guidelines (32) (33) (34) .
Selectivity
Method selectivity was evaluated by analyzing six reconstituted blank blood samples and six drug-free postmortem blood samples without the addition of the mixed IS. Furthermore, blank blood was extracted and analyzed with each batch of samples to evaluate matrix interferences from samples. To evaluate interferences from the IS, three samples of each blank blood type were analyzed after the addition of a mixed internal standard (containing methadone-d 3 , prazepam and cyclobarbitone). In addition, three blank blood samples spiked with all analytes at the highest concentration levels of the assay (2 mg/L for basic and 6 mg/L for acidic) were analyzed without IS in order to evaluate possible interferences from the IS.
Linearity and range
To establish the linear range for analytes that were to be quantified, blank blood was spiked at nine different levels and extracted as previously described. Eight replicates (n = 8) at each of nine concentrations for basic analytes (0.05, 0.1, 0.5, 1, 1.5, 2, 2.5, 3 and 3.5 mg/L) and for acidic analytes (0.1, 0.5, 1, 2, 4, 6, 8, 10 and 12 mg/L) were analyzed. Using TargetLynx (Waters MassLynx 4.1), calibration curves were obtained by plotting the ratio of analyte peak area to the internal standard peak area versus the analyte concentration. Quantification was achieved by using the molecular ion of the 
Accuracy and Precision
Intra-run (within-run) precision and accuracy was determined by the analysis of seven replicates spiked at low, medium and high concentrations. For basic analytes the low, medium and high concentrations were 0.2, 1 and 2 mg/L respectively and acidic analytes were 1, 3 and 5 mg/L. Inter-run (between-run) precision was determined by the analysis of seven replicates of low, medium and high concentrations as mentioned previously by different operators on three separate days. The acceptance criteria for the precision and accuracy studies were ≤15% CV (coefficient of variation) and ±15% bias (expressed as percentage mean relative error, %MRE) respectively for medium and high levels. For the low level, acceptance criteria of ≤20% CV and ±20% bias were used.
Limit of Detection (LOD) and Limit of Quantification (LOQ)
The LOD was assessed by spiking blank blood with different volumes of acidic and basic mixed working standard solutions to give concentrations of 0.001, 0.005, 0.007, 0.01, 0.05 and 0.07 mg/L. Seven replicates at each concentration level were extracted and analyzed by two different operators (n = 14). The LOD was determined as the lowest concentration at which an analyte gives a reproducible response with a signal-to-noise (S/N) ratio of 3 or greater for both precursor and product ions. LOQ was determined by spiking blank blood at concentrations of 0.01, 0.05, 0.1, 0.3, 0.4 and 0.5 mg/L in replicate (n = 7). An LOQ for each analyte was determined as the minimum concentration which exhibited S/N ratio > 10 without exceeding 20% CV and %MRE ± 20%.
Sensitivity
The sensitivity (Δy/Δx) of the method is defined as the rate of change of the measured response (Δy) with a change in the concentration of analyte (Δx) i.e., the slope/gradient of the calibration curve.
Matrix effects and recovery
ME is the tendency for the ionization of an analyte to be either enhanced or suppressed by co-eluting matrix components. It is determined by comparison of peak areas between a neat standard and a spiked sample after extraction and reported as a percentage. Values above 100% indicate ion enhancement, whereas values below 100% suggest ion suppression. Recovery or extraction efficiency is the percentage of analyte that is successfully extracted from the matrix. It is determined by comparing peak areas of analytes spiked before and after extraction.
Samples were prepared at 3 different concentrations and extracted in replicate (n = 5). Basic analytes were prepared at 0.1, 1 and 2 mg/L while acidic analytes were prepared at 0.5, 3 and 6 mg/L. ME and recovery studies were conducted according to the procedure published by Matuszewski et al. (35) . Three sets of samples were prepared: Set 1 contained pure standards, Set 2 comprised samples that were spiked with mixed standards after extraction and Set 3 comprised samples spiked with mixed standards before extraction. Different types of blood specimens were assessed for ME: blank blood, non-decomposed, decomposed and highly decomposed postmortem blood.
Processed sample stability
Replicates (n = 6) of low, medium and high QCs for both basic and acidic analytes were analyzed immediately after extraction followed by the analysis of the samples after the samples had remained in the autosampler, maintained at a constant temperature of 10 o C, for a period of 48 h. The analytes were regarded as stable when the difference of the average peak area of an analyte at the initial time (time zero, t 0 ) and the peak area after 48 h in the autosampler, did not exceed 15% (34) .
Long term storage stability and freeze/thaw stability
Replicates (n = 6) of low, medium and high QCs were analyzed weekly over a 3 month period after being stored in a refrigerator at 4 o C. Frozen samples were also assessed which were kept in a freezer at −18 o C. For the freeze/thaw stability study, six replicates of low, medium and high QCs were analyzed after each freeze/thaw cycle for a total of four freeze/thaw cycles.
Carryover
Basic analytes were examined at concentrations of 5, 10, and 20 mg/L and acidic analytes at concentrations of 8, 10, 20 and 30 mg/L. After injection of each concentration, three blank methanol solutions were injected. Carryover for a particular analyte was determined as the concentration when the analyte exceeded its LOD peak area in any of the blank methanol injections.
Dilution integrity
To determine the possibility of sample reanalysis when concentrations of analytes are outside the range of the calibration curve, dilution integrity was evaluated. Blank blood was spiked with 18 QC analytes (see Table I ) at concentration 4, 10, 20 and 40 mg/L and diluted for comparison with milli-Q water (n = 5) and blank blood (n = 5) at dilution ratio 1:2, 1:5, 1:10 and 1:20.
Results and Discussion
For analyses requiring chromatographic separation, it is crucial that a sample clean-up procedure is employed prior to analyses to provide satisfactory results and to preserve instrument health (36) . As such, it is often challenging to develop extraction procedures for biological matrices which can isolate a broad range of basic, neutral and acidic analytes that have varying physico chemical properties. In this study, traditional extraction procedures for basic and acidic analytes in blank blood were investigated at concentrations of 0.5 and 1.0 mg/L respectively and the recoveries evaluated. Solid phase extraction (SPE) was evaluated using various mixed-mode cartridges (OASIS-MCX, XCEL-1, Telos Neo PRP, Telos H-CX, CS DAU 203, Bond Elute, Evolute-ABN, Isolute-HCX, Strata-XC and Drug Prep1) with different elution solvents such as methanol and ethyl acetate (EtOAc). In addition, liquid-liquid extraction (LLE) was investigated with different solvent combinations (dichloromethane (DCM)/isopropyl alcohol (IPA), DCM/IPA/EtOAc and 1-chlorobutane) at different pH levels. Acetonitrile is a good extraction solvent for many acidic and basic compounds, however, it is miscible with water and does not easily separate into clear organic/aqueous layers. A technique called salting-out assisted liquid-liquid extraction (SALLE) can decrease acetonitrile's miscibility with water by saturating the aqueous layer with a salt, namely, NaCl (37) . SALLE with acetonitrile was evaluated using a saturated NaCl solution using Table III . Accuracy and precision data for basic analytes at low (0.2 mg/L), medium (1 mg/L) and high (2 mg/L) concentrations ultrasonication following the addition of acetonitrile and it was found that for most analytes the recoveries were >85% (Table I) . After evaluation of all the recovery data for evaluated extraction procedures, it was determined that the SALLE procedure was most suitable for the purpose of isolating and partitioning a broad panel of 185 drugs in postmortem blood.
Positive identification of target analytes was achieved by the accurate measurement (±5 ppm) of the monoisotopic mass
, the presence of one major product ion (±5 ppm) and an experimental retention time within ±5% of the predicted retention time of the previously analyzed certified reference materials (CRMs) ( Table I ). In addition, the peak area ratios of the monoisotopic mass and major product ions were found to be relatively stable and characteristic when analyzed at 8 different concentration levels (0.05-2 mg/L) over 20 batches during a period of several months. Therefore, average peak area ratios were used to compare those from authentic forensic samples. It has been established that for a positive identification, the experimental ion ratio value had to be within ±20% of the predicted value. Only 5 analytes had ion ratio values between 20-25% and 6 analytes with ion ratio values exceeding ±25%. To check for compliance, Microsoft Excel 2010 spreadsheet was set up to calculate the difference between the predicted and actual retention times and ion ratios for each analyte. Several isobaric pairs (n = 9) of analytes which exist in the panel of analytes (i.e., methamphetamine/phentermine, 3,4-methylenedioxymethamphetamine (MDMA)/methedrone, morphine/ hydromorphone, temazepam/clobazam, etc.) were able to be differentiated Data sets marked in bold indicate that the accuracy or precision data lay outside of the allowed tolerance. Data sets marked in bold indicate that the accuracy or precision data lay outside of the allowed tolerance. by chromatographic separation using different product ions and peak arearatios(seeresultsinTablesI andII ). Only2pairsofisobaricanalytes (pseudoephedrine/ephedrine and quinine/quinidine) could not be distinguishedinthisassay.Identificationofthelatterwasachievedusingan LC-MS/MSmethoddevelopedin-house.
Validation experiments
The method described was validated according to internationally recognized guidelines (32) (33) (34) . The method was selective and showed no interferences from endogenous compounds and other analytes with the exceptions mentioned previously. No carryover was observed for the majority of basic analytes after a 10 mg/L injection, however, amiodarone was detected in the first methanol injection at this concentration. For acidic analytes, there was no carryover observed in the first methanol injection after a 20 mg/L injection except for gliclazide and warfarin. Therefore, carryover from postmortem samples with concentrations of analytes greater than 10 mg/L is a possibility. Samples exhibiting analyte concentrations higher than the carryover limit must be diluted and re-analyzed. The samples succeeding the carryover sample should be checked for carryover analytes and re-analyzed if necessary. The calibration curves for all analytes showed satisfactory linearity with correlation coefficients (r 2 ) > 0.96 for both basic and acidic analytes over concentration ranges of 0.05-2 mg/L and 0.1-6 mg/L respectively. Olanzapine demonstrated unsatisfactory linearity due to poor recoveries with the SALLE method and was subsequently removed from the assay entirely. In addition, valproic acid which also exhibited poor linearity was used only for screening. Table I outlines the data obtained from the LOD and LOQ experiments with most analytes having LOD concentrations between 0.001-0.05 mg/L and LOQ concentrations at either 0.05 or 0.1 mg/L. The accuracy and precision data outlined in Tables III and IV shows that most analytes had acceptable accuracy and precision for all concentrations examined. The accuracy and precision of most amphetamines was unacceptable and were further analyzed using a GC-MS method developed in-house. Analytes detected by screening (Set C) were quantified by LC-MS/MS. For the dilution integrity study, acceptable precision <20% CV and ±20% bias was achieved for samples diluted with blank blood. Comparison of relative matrix effects for different levels of blood decomposition (Table V) indicated that the ME for some analytes, which originated from the same analyte concentration, significantly differs at different levels of decomposition. For highly decomposed blood, significant ion suppression was observed for atenolol (12-16%), metronidazole (27-31%), ranitidine (23-27%), salbutamol (24-38%), sotalol (20-23%), diclofenac (26-42%), ibuprofen (20-21%) and lamotrigine (19-20%) . For blank, nondecomposed and decomposed blood samples, none of the observed ion-suppression or enhancement caused a significant enough loss in sensitivity to interfere with accurate quantification. Interestingly, metformin, which exhibited severe ion suppression at all levels of blood decomposition, still yielded acceptable linearity and sensitivity in this assay. All analytes were stable after remaining in the autosampler for 48 h, three months storage in a freezer (−18 o C) and after four freeze-thaw cycles.
Application to Case Work
After validation studies, the method was applied to a number of forensic postmortem samples to confirm that the results produced from this method were consistent with results obtained from other validated methods. The method was applied to over 5000 cases for screening and quantification received in the period from February 2013 to November 2014. The number of target analytes detected and the postmortem blood concentration ranges are presented in Table VI , with the listed concentration ranges referring to the lowest and the highest concentrations observed in this practical study. For some analytes, the total number of cases included concentrations that were detected between the LOD and LOQ levels, but are listed at the LOQ level.
Common over-the-counter analgesics were the most frequently detected analytes in cases which were analyzed during the selected period. They were present in 2195 cases with paracetamol (n = 1209, 0.5-270 mg/L) and ibuprofen (n = 617, 0. 
Conclusions
A simple and sensitive UPLC-QTOF-MS method for the screening of more than 185 drugs and metabolites and for the quantification of more than 90 drugs in whole blood was developed and validated according to international guidelines. The simple salting-out assisted liquid-liquid extraction procedure achieved good recoveries for most analytes ranging from 80% to 100%. The method was tested on a number of actual forensic samples producing consistent results that compared well with results obtained from other validated methods. 
